PO-0952: Variation in dynamic 18FFDG PET parameters in breast cancer PDX and correlation to treatment outcome von Kristian, A, Revheim, M.E, Mælandsmo, G, Engebråten, O, Malinen, E

Volltext

Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma von Revheim, M.E, Winge-Main, A.K, Hagen, G, Fjeld, J.G, Fosså, S.D, Lilleby, W

Volltext

1108P Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas von Butt, B.P., Stokmo, H.L., Ladekarl, M., Mitkina Tabaksblat, E., Sorbye, H., Revheim, M.E., Hjortland, G.O.

Volltext

P102 First-in-human study of AB001, a prostate-specific membrane antigen (PSMA) targeted 212Pb alpha radioligand, in patients with metastatic castration resistant prostate cancer (... von Berner, K., Hernes, E., Kvassheim, M., Bastiansen, J., Selboe, S., Bakken, C.L., Bruland, Ø.S., Bouzelmat, L., Jardine, V.L., Revheim, M.E., Stokke, C.

Volltext

PP25.10 A PROPOSED METHOD FOR ESTIMATION OF DISEASE BURDEN IN PATIENTS WITH MULTIPLE MYELOMA MEASURED BY [18F]FDG AND [18F]FLUCICLOVINE von Blakkisrud, J., Connelly, J., Sherwani, A., Schjesvold, F., Revheim, M.E., Stokke, C.

Volltext